LOUMEAU ERIC J 4
4 · ANAPTYSBIO, INC · Filed Jan 6, 2026
Insider Transaction Report
Form 4
ANAPTYSBIO, INCANAB
LOUMEAU ERIC J
CHIEF LEGAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2026-01-03+7,287→ 16,234 total - Sale
Common Stock
2026-01-05$43.26/sh−2,983$129,045→ 13,251 total - Exercise/Conversion
Restricted Stock Unit
2026-01-03−7,287→ 14,575 total→ Common Stock (7,287 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F3]The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.